IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

SAJJADI, ELHAM
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.599
AS - Asia 4.435
NA - Nord America 3.449
SA - Sud America 497
AF - Africa 143
OC - Oceania 57
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.181
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.245
DE - Germania 1.992
CN - Cina 1.928
SG - Singapore 1.022
IT - Italia 910
BR - Brasile 372
GB - Regno Unito 332
HK - Hong Kong 293
IN - India 225
RU - Federazione Russa 207
FR - Francia 182
SE - Svezia 172
NL - Olanda 162
BD - Bangladesh 150
VN - Vietnam 147
ES - Italia 141
JP - Giappone 109
CA - Canada 102
ID - Indonesia 90
FI - Finlandia 87
IE - Irlanda 86
MX - Messico 73
TR - Turchia 69
KR - Corea 66
IR - Iran 54
PL - Polonia 54
AU - Australia 47
TW - Taiwan 47
AT - Austria 36
PT - Portogallo 36
CO - Colombia 34
EG - Egitto 34
PH - Filippine 32
SA - Arabia Saudita 32
ZA - Sudafrica 32
GR - Grecia 30
BE - Belgio 29
CH - Svizzera 29
TH - Thailandia 26
IL - Israele 25
AR - Argentina 22
MY - Malesia 20
IQ - Iraq 18
PK - Pakistan 18
RO - Romania 18
DK - Danimarca 17
CL - Cile 15
EC - Ecuador 15
NG - Nigeria 14
AE - Emirati Arabi Uniti 13
LT - Lituania 12
PE - Perù 12
UA - Ucraina 12
NO - Norvegia 11
UY - Uruguay 11
NZ - Nuova Zelanda 10
VE - Venezuela 10
CI - Costa d'Avorio 9
CR - Costa Rica 9
CZ - Repubblica Ceca 9
MA - Marocco 9
JO - Giordania 8
KE - Kenya 8
SN - Senegal 7
DZ - Algeria 6
GH - Ghana 6
HU - Ungheria 6
TN - Tunisia 6
PA - Panama 5
PY - Paraguay 5
RS - Serbia 5
UZ - Uzbekistan 5
AL - Albania 4
BG - Bulgaria 4
HN - Honduras 4
LB - Libano 4
LK - Sri Lanka 4
LU - Lussemburgo 4
PS - Palestinian Territory 4
SC - Seychelles 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GT - Guatemala 3
KW - Kuwait 3
MO - Macao, regione amministrativa speciale della Cina 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CY - Cipro 2
ET - Etiopia 2
KG - Kirghizistan 2
LY - Libia 2
MD - Moldavia 2
NP - Nepal 2
AO - Angola 1
BO - Bolivia 1
BY - Bielorussia 1
Totale 13.168
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 1.800
Singapore 563
Dallas 495
Ashburn 369
Hong Kong 226
Milan 223
San Jose 193
Beijing 177
Chandler 171
Southend 169
Hefei 146
Council Bluffs 141
Los Angeles 125
Shanghai 123
Guangzhou 110
Santa Clara 99
New York 90
Fairfield 89
Dublin 85
Jakarta 63
Bengaluru 57
Nanjing 57
Lauterbourg 53
Helsinki 52
São Paulo 52
Shenzhen 51
Moscow 48
Ho Chi Minh City 47
Princeton 46
Tokyo 46
Wilmington 46
Boardman 45
Istanbul 44
Rome 44
Chicago 42
Hanoi 41
Seattle 39
Buffalo 38
Houston 37
Toronto 36
Ann Arbor 33
Nuremberg 33
Shenyang 32
Redwood City 31
Seoul 31
Chengdu 30
Hangzhou 28
Munich 28
The Dalles 28
Bologna 27
Cangzhou 27
Woodbridge 27
Wuhan 27
Erechim 26
Vienna 26
Cambridge 24
Amsterdam 23
Athens 23
Des Moines 22
Hyderabad 22
London 22
Naples 22
Bogotá 21
Fuzhou 21
Berlin 20
Paris 20
Phoenix 20
Jinan 19
Lappeenranta 19
Atlanta 18
Mexico City 18
Cairo 17
Chongqing 17
Gainesville 17
San Diego 17
Turin 17
Columbus 16
Huntley 16
Jeddah 16
Taipei 16
Changsha 15
Madrid 15
Zhengzhou 15
Bangkok 14
Warsaw 14
Washington 14
Barcelona 13
Changchun 13
Madison 13
Melbourne 13
Tehran 13
Tianjin 13
Xi'an 13
Brussels 12
Cape Town 12
Düsseldorf 12
Florence 12
Grafing 12
Ribeirão Preto 12
Valencia 12
Totale 7.557
Salva come PNG Salva come JPEG
Nome #
CAR-T cell therapy for triple-negative breast cancer and other solid tumors: preclinical and clinical progress 2.642
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management 709
Determination of Mismatch repair status in human cancer and its clinical significance : does one size fit all? 561
Computational pathology to improve biomarker testing in breast cancer: how close are we? 323
PTEN Expression as a Complementary Biomarker for Mismatch Repair Testing in Breast Cancer 314
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer 312
Pten alterations and their role in cancer management: Are we making headway on precision medicine? 287
HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer 278
Immunotherapy in breast cancer patients: A focus on the use of the currently available biomarkers in oncology 260
Integrating Biological Advances Into the Clinical Management of Breast Cancer Related Lymphedema 254
Osteoclast-like stromal giant cells in breast cancer likely belong to the spectrum of immunosuppressive tumor-associated macrophages 253
Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists 248
Impact of Rehabilitation on Breast Cancer Related Fatigue : A Pilot Study 218
How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer : Between Biomarkers and Novel Cell-Based Approaches 216
Early Breast Cancers During Pregnancy Treated With Breast-Conserving Surgery in the First Trimester of Gestation: A Feasibility Study 215
Mismatch repair-deficient hormone receptor-positive breast cancers : Biology and pathological characterization 214
Characterization of the immune microenvironment in malignant pleural mesothelioma reveals prognostic subgroups of patients 213
Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management 212
Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials 212
Mismatch Repair Status Characterization in Oncologic Pathology : Taking Stock of the Real-World Possibilities 211
CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype 204
Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling 204
Tumor-infiltrating lymphocytes (TILs) in paired samples from patients with phenotypic switch from early luminal-like to metastatic triple-negative breast cancer 200
Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management 195
Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles 190
Cellular immunotherapy in breast cancer: The quest for consistent biomarkers 189
Integrated analysis of mismatch repair, PD-L1, and immune microenvironment status in pregnancy-associated breast cancers 185
Prognostic value of TILS (tumor infiltrates lymphocytes) and PET in pleural mesothelioma: retrospective analysis of monocentric experience 184
A Model to Predict Upstaging to Invasive Carcinoma in Patients Preoperatively Diagnosed with Low-Grade Ductal Carcinoma In Situ of the Breast 181
Mismatch repair testing in breast cancer: the path to tumor-specific immuno-oncology biomarkers 179
Low-risk triple-negative breast cancers: Clinico-pathological and molecular features 175
Mismatch Repair System Genomic Scars in Gastroesophageal Cancers: Biology and Clinical Testing 173
Metaplastic breast cancers and triple-negative breast cancers of no special type: are they prognostically different? A systematic review and meta-analysis 169
Physical Exercise with or without Whole-Body Vibration in Breast Cancer Patients Suffering from Aromatase Inhibitor—Induced Musculoskeletal Symptoms : A Pilot Randomized Clinical Study 166
THE IMMUNE MOLECULAR LANDSCAPE OF BREAST CANCER DURING PREGNANCY 165
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey 162
Immune microenvironment dynamics in breast cancer during pregnancy: impact of gestational age on tumor-infiltrating lymphocytes and prognosis 156
Trop-2 as an Actionable Biomarker in Breast Cancer 154
Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing Methods 144
The molecular landscape of breast mucoepidermoid carcinoma 143
Letter to the editor regarding the article “pregnancy-associated breast cancer: a multicenter study comparing clinicopathological factors, diagnosis, and treatment outcomes with non-pregnant patients” 143
Lymphedema rehabilitation using self-adaptive inelastic compression in breast cancer: A proof-of-principle study 137
PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scores 137
Pathological identification of HER2-low breast cancer: Tips, tricks, and troubleshooting for the optimal test 135
Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence 128
Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study 121
Analytical Performance of Next-Generation Sequencing and RT-PCR on Formalin-Fixed Paraffin-Embedded Tumor Tissues for PIK3CA Testing in HR+/HER2− Breast Cancer 116
Exercise therapy to reduce breast cancer fatigue: Results from the EXPECT study 115
Biomarkers for precision immunotherapy in the metastatic setting : hope or reality? 108
The Regulatory Landscape of Biobanks In Europe: From Accreditation to Intellectual Property 105
ctDNA analysis in the personalized clinical management of gastroesophageal adenocarcinoma: turning hope into reality 100
HER2 Testing in Breast and Gastric Cancer with CDH1 Germline Mutations 95
Malignancies in Patients with Celiac Disease: Diagnostic Challenges and Molecular Advances 92
Understanding the biology of volumetric muscle loss for an individualized exercise rehabilitation approach in breast cancer patients 82
The evolving landscape of anatomic pathology 68
Improving HER2 testing reproducibility in HER2-low breast cancer 51
Commentary: Mismatch Repair Deficiency and Microsatellite Instability in Triple-Negative Breast Cancer: A Retrospective Study of 440 Patients 49
null 6
Totale 13.458
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.556
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.556
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 0 0 0 0 0 0 0 67 52
2021/2022548 70 40 28 35 35 40 40 28 86 44 24 78
2022/2023682 64 58 53 73 52 115 17 37 84 6 48 75
2023/20242.654 99 92 115 141 208 181 358 334 197 274 334 321
2024/20254.012 342 398 352 384 288 257 219 337 280 323 308 524
2025/20264.784 564 713 577 372 361 261 487 253 458 304 434 0
Totale 13.458